AGP Picks
View all

Latin America Investor Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Investor Daily.

Press releases published on April 3, 2026

A LEGACY THAT ENDURES: FATHER AND SON HONORED FOR TRANSFORMATIVE, GENERATIONAL IMPACT IN EDUCATION
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
Jena Acquisition Corporation II Announces Non-Compliance with Section 802.01B of the NYSE Listed Company Manual which Requires the Company to Maintain a Minimum of 300 Public Stockholders
Midland States Bancorp, Inc. To Announce First Quarter 2026 Financial Results On Thursday, April 23
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
AIOS Tech Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FAR AI Opens Node Registrations, Giving GPU Owners a New Way to Earn From AI Demand
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
Spyre Therapeutics Announces Grants of Inducement Awards
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
First Hawaiian to Report First Quarter 2026 Financial Results on April 24, 2026
Superior Energy Introduces EcoReach™, a Next-Generation, Field-Proven Completions Solution
RCM Technologies, Inc. Announces Fourth Quarter And Fiscal Year 2025 Results
DBM Global to Pay Cash Dividend
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans
Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)

Share this page:

Sign up for:

Latin America Investor Daily

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.